TITLE

Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers

AUTHOR(S)
Jarrick, Simon; Lundberg, Sigrid; Welander, Adina; Fored, C. Michael; Ludvigsson, Jonas F.
PUB. DATE
January 2017
SOURCE
Clinical Epidemiology;Jan2017, Vol. 9, p67
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aims: The aims of this study were to validate the diagnosis of IgA nephropathy (IgAN) in Swedish biopsy registers against patient charts and to describe the clinical characteristics of patients with a biopsy indicating IgAN. Methods: This is a population-based cohort study. Out of 4,069 individuals with a renal biopsy consistent with IgAN (biopsies performed in 1974-2011), this study reviewed patient charts of a random subset of 127 individuals. Clinical and biopsy characteristics at the time of biopsy were evaluated, and positive predictive values (PPV) were calculated with 95% confidence intervals (CI). Results: Out of 127 individuals with a renal biopsy consistent with IgAN, 121 had a likely or confirmed clinical diagnosis of IgAN, primary or secondary to Henoch-Schönlein purpura, yielding a PPV of 95% (95% CI =92%-99%). The median age at biopsy was 39 years (range: 4-79 years); seven patients (6%) were <16 years. The male to female ratio was 2.8:1. The most common causes for consultation were macroscopic hematuria (n=37; 29%), screening (n=33; 26%), and purpura (n=14, 11%). In patients with available data, the median creatinine level was 104 μmol/L (range 26-986 μmol/L, n=110) and glomerular filtration rate 75 mL/min/1.73m2 (range 5-173 mL/min/1.73m2, n=114). Hypertension was noted in 59 (46%) individuals. IgA deposits were reported in 97% of the biopsy records (n=123), mesangial hypercellularity in 76% (n=96), C3 deposits in 89% (n=113), and C1q deposits in 12% (n=15). Conclusion: A histologic diagnosis of IgAN has a high PPV for a diagnosis of IgAN confirmed by review of patient charts.
ACCESSION #
121172950

 

Related Articles

  • Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese. Cheng, Wenrong; Zhou, Xujie; Zhu, Li; Shi, Sufang; Lv, Jicheng; Liu, Lijun; Zhang, Hong // Nephrology Dialysis Transplantation;Aug2011, Vol. 26 Issue 8, p2544 

    Background. IgA nephropathy (IgAN) is the leading cause of end-stage renal disease (ESRD) in China considering different compositions of ESRD causes in different ethnicities. A recent genome-wide association study (GWAS) indicated that the MYH9 gene was significantly associated with non-diabetic...

  • Genetic Polymorphism of NPHS1 Modifies the Clinical Manifestations of Ig A Nephropathy. Narita, Ichiei; Goto, Shin; Saito, Noriko; Song, Jin; Kondo, Daisuke; Omori, Kentaro; Kawachi, Hiroshi; Shimizu, Fujio; Sakatsume, Minoru; Ueno, Mitsuhiro; Gejyo, Fumitake // Laboratory Investigation (00236837);Aug2003, Vol. 83 Issue 8, p1193 

    Nephrin, the molecule responsible for congenital nephrotic syndrome of Finnish type, is crucial in maintaining the glomerular filtration barrier. Recently, its complete gene structure and common gene polymorphisms in its exons have been reported, although the functional and clinical significance...

  • Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Svobodova, Barbora; Honsova, Eva; Ronco, Pierre; Tesar, Vladimir; Debiec, Hanna // Nephrology Dialysis Transplantation;Jul2013, Vol. 28 Issue 7, p1839 

    Background Antibodies against M-type phospholipase A2 receptor (PLA2R) are serological markers of disease activity in patients with idiopathic membranous nephropathy (iMN). To determine the most sensitive test for the diagnosis of PLA2R-related membranous nephropathy (MN) irrespective of...

  • How early renal biopsy has to be performed in children with isolated asymptomatic proteinuria? Coppo, Rosanna // Nephrology Dialysis Transplantation;Aug2012, Vol. 27 Issue 8, p3016 

    No abstract available.

  • Reply. Macedo, Etienne; Del Granado, Rolando Claure; Mehta, Ravindra L. // Nephrology Dialysis Transplantation;Dec2010, Vol. 25 Issue 12, p4114 

    No abstract available.

  • Urine output criteria for the diagnosis of early stages of acute kidney injury. Muddying the waters? Schiffl, Helmut // Nephrology Dialysis Transplantation;Dec2010, Vol. 25 Issue 12, p4114 

    No abstract available.

  • Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Wang, Gang; Kwan, Bonnie Ching-Ha; Lai, Fernand Mac-Moune; Chow, Kai-Ming; Li, Philip Kam-Tao; Szeto, Cheuk-Chun // Disease Markers;2011, Vol. 30 Issue 4, p171 

    Background: Previous studies suggested miR-146a and miR-155 play important roles in innate and adaptive immune responses. We studied intra-renal and urinary levels of miR-146a and miR-155 in patients with immunoglobulin A nephropathy (IgAN). Methods: Intra-renal and urinary levels of miR-146a...

  • Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Wada, Yukihiro; Ogata, Hiroaki; Takeshige, Yui; Takeshima, Akiko; Yoshida, Noriyo; Yamamoto, Masahiro; Ito, Hidetoshi; Kinugasa, Eriko // Clinical & Experimental Nephrology;Feb2013, Vol. 17 Issue 1, p73 

    Background: Immunoglobulin (Ig) A nephropathy (IgAN) is characterized by mesangial deposits of IgA1 and C3, often with co-deposits of IgG. We attempted to clarify the clinical significance of mesangial IgG deposition in patients with IgAN. Methods: We retrospectively reviewed 57 patients who...

  • Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy. Ohsawa, Isao; Kusaba, Gaku; Ishii, Masaya; Sato, Nobuyuki; Inoshita, Hiroyuki; Onda, Kisara; Hashimoto, Azusa; Nagamachi, Seiji; Suzuki, Hiyori; Shimamoto, Mamiko; Ohi, Hiroyuki; Horikoshi, Satoshi; Tomino, Yasuhiko // Nephrology Dialysis Transplantation;Jul2013, Vol. 28 Issue 7, p1856 

    Background The aim of the present study was to explore the significance of extraglomerular (Bowman's capsule and/or arteriole) C3 (ex-C3) deposits in IgA nephropathy (IgAN). Methods One hundred and seventy patients with IgAN were divided into two groups: Group A (n = 79), patients who did not...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics